Recruiting
RSV in older adults: WCS-RSV-3301
A Phase 2 study of an antiviral given within three days of symptom onset in adults aged 60 and over.
Home/Areas of Study/RSV
Our commitment to clinical research for RSV
Respiratory syncytial virus is usually mild, but in older adults and people with heart or lung conditions it is a common cause of hospital admission. Our studies focus on exactly those groups.
1 in 4
RSV hospital admissions in adults involve someone aged 65 or over
4 studies in this area
Featured trials
A selection of what is open right now. Eligibility is decided by the investigator at a study site, never by this page.
Not yet recruiting
RSV in adults with chronic lung disease: WCS-RSV-3318
A Phase 2 study in adults with COPD or asthma and confirmed RSV infection.
Studies open and close continually. We can text you when a new one opens near you.
Get study alertsOur research
What are we studying?
Learn more about our areas of research and see whether one of our clinical trials might be right for you.
RSV in older adults
- Almost everyone catches RSV in childhood, and most people catch it again periodically through life without serious consequence.
- Immunity weakens with age, and in adults over 60 an infection can escalate to pneumonia or worsen existing heart failure.
- Our studies test whether treating early changes the course of that illness.
RSV with chronic heart or lung disease
- For people with COPD, asthma or heart failure, RSV frequently triggers a flare of the underlying condition rather than presenting as a simple virus.
- That group is routinely excluded from respiratory studies, which is precisely why we are enrolling them.
Want to understand what taking part actually involves before you go further?
Read the guide